Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANVS
#3492
Annovis Bio, Inc.
2.6
9
-2.54%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-2.54%
Mudança mensal
-9.12%
Mudança em 6 meses
+14.47%
Mudança anual
+46.20%
Fechamento anterior
2.7
6
Open
2.6
6
Bid
Ask
Low
2.6
6
High
2.6
9
Volume
28
Mercados
Ações
Cuidados de saúde
ANVS
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
13.8 M
19.49 M
19.49 M
19.49 M
26.5 M
—
Valuation ratios
Enterprise value
98.57 M
87.46 M
6.99 M
25.15 M
39.57 M
159.19 M
Price to earnings ratio
-1.71
-2.18
-0.74
-1.4
-1.74
-6.06
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-3.61
-2.81
-0.89
-1.31
-1.31
-6.32
Price to book ratio
-10.34
6.61
0.59
0.6
0.55
8.36
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.88
-0.42
-0.21
-0.29
-0.42
-1.34
Return on equity %
-1.79
-0.63
-0.23
-0.34
-0.55
-1.75
Return on invested capital %
7 128.56
—
-580.57
519.35
-2 240.34
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.38
2.83
9.03
6.26
4.2
22.32
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.28
-0.68
-0.46
-0.28
-0.18
-1.6
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.1
0.87
1.27
0.93
0.81
3.88
Net current asset value per share
1.12
0.9
1.3
0.95
0.83
3.98
Tangible book value per share
0.62
0.76
1.38
0.99
0.7
3.83
Working capital per share
0.65
0.58
1.15
0.8
0.63
3.17
Book value per share
0.62
0.76
1.38
0.99
0.7
3.83
Notícias
Annovis Bio iniciará estudo de longo prazo para medicamento contra Parkinson em janeiro
Annovis Bio to launch long-term Parkinson’s drug study in January
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops
Diretor da Annovis Bio, Hoffman, compra ações no valor de US$ 193.794
Annovis Bio director Hoffman buys $193,794 in shares
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling
Diretor da Annovis Bio, Hoffman, compra US$ 69,9 mil em ações ANVS
Annovis Bio director Hoffman buys $69.9k in ANVS stock
Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)
Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion
Annovis Bio raises $3.4 million in registered direct offering